Price-fixing lawsuit deals another blow to already fragile Teva, experts say | The Times of Israel
Closure of another criminal case will help Teva's new CEO to focus on return to growt | Ctech
Teva enlarges workforce for first time since 2016 - Globes
Teva Pharmaceutical reports 5% fall in Q4 2022 revenue
Teva's stunning list of cuts targets 14K jobs, $3B in costs and plants around the globe | Fierce Pharma
Huntington's treatment helps Teva beat profit estimates as CEO eyes newer drug opportunities | Reuters
Teva beats on Q3 revenue and raises guidance - Globes
Teva Pharmaceutical Industries Limited - AnnualReports.com
Teva Pharmaceutical Industries Ltd. - Investors
Teva Pharmaceutical Industries Limited (NYSE:TEVA) Shares Acquired by Wellington Management Group LLP
Teva Pharmaceutical Industries (NYSE:TEVA) Has A Somewhat Strained Balance Sheet - Simply Wall St News
Teva Pharmaceutical Industries Ltd (TEVA) Reports Solid Growth in 2023 Earnings
Teva Pharmaceutical (TEVA) bets on market reopening to regain momentum | AlphaStreet
DEF 14A
Teva Pharmaceuticals on X: "Teva just announced its Q2 2022 financial results. View the press release here: https://t.co/OGECc00hWU Forward-looking statements are subject to the cautionary note included in our Q2 2022 press
Teva Pharmaceuticals on X: "Teva just announced its Q4 and full year 2023 financial results. View the press release here: https://t.co/RZ6UsL39sy Forward-looking statements are subject to the cautionary note included in our
Teva Pharmaceutical Industries Ltd. - Investors
Teva Pharmaceutical Industries Limited Trade Ideas — NYSE:TEVA — TradingView
Teva Pharmaceutical Industries Ltd (TEVA) Reports Solid Growth in 2023 Earnings
Teva Pharma Q2 Revenues Drop 18% | BioSpace
The Mighty Teva Pharmaceutical: Unveiling A Bullish Scenario You Must Consider (NYSE:TEVA) | Seeking Alpha
Investors sue Teva over $41B Actavis deal - Drug Delivery Business
Teva Pharmaceutical Industries Limited 2022 Q4 - Results - Earnings Call Presentation (NYSE:TEVA) | Seeking Alpha
